Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

NCT05081063 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT05081063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05081063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients
Lead sponsor
Loma Linda University
Phase
Phase 3
Overall status
Completed
Start date
March 5, 2022
Completion date
May 15, 2023
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute blood loss anemia, hemorrhagic shock, traumatic brain injury